Skip to main content
TipRanks
Go Ultimate75% OFF

PTC Therapeutics (P91) Ownership - Who Owns PTC Therapeutics?

1 Followers

PTC Therapeutics (P91) Ownership Overview

  • 3.02% Insiders
  • 30.34% Mutual Funds
  • 28.49% Other Institutional Investors
  • 29.06% ETFs
  • 9.08% Public Companies and Individual Investors

The ownership structure of PTC Therapeutics (CH:P91) stock is a mix of institutional, retail, and individual investors. Approximately 87.90% of the company’s stock is owned by Institutional Investors, 3.02% is owned by Insiders, and 9.08% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
May 14, 2026Matthew B. Klein$917,154
Apr 22, 2026Matthew B. Klein$202,094
Apr 05, 2026Lee Scott Golden$56,364
Mar 12, 2026Matthew B. Klein$170,581

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Manning & Napier Advisors LlcCHF9,495
Dec 31, 2025Bridgewater Associates, LpCHF1,232,754
Dec 31, 2025Hussman Strategic Advisors IncCHF1,914,192
Dec 31, 2025Royce & Associates LlcCHF6,137,112

Top Shareholders

CH:P91 top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.14,397,317Institution17.23%―
Ishares10,274,419Institution12.30%―
Vanguard7,017,913Institution8.40%―
Vanguard Index Funds6,586,978Institution7.88%―
Spdr3,851,189Institution4.61%―
Vanguard Specialized Funds2,310,268Institution2.77%―
Janus Investment Fund1,901,852Institution2.28%―
Michael Schmertzler1,454,860Insider1.74%―
Steve Weber1,236,579Institution1.48%―
Fidelity Salem Street Trust1,000,852Institution1.20%―

Top Mutual Fund Holders

CH:P91 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds6,586,978Institution7.88%―
Vanguard Specialized Funds2,310,268Institution2.77%―
Janus Investment Fund1,901,852Institution2.28%―
Fidelity Salem Street Trust1,000,852Institution1.20%―
Fidelity Concord Street Trust914,427Institution1.09%―
Manager Directed Portfolios832,255Institution1.00%―
Capitol Series Trust780,300Institution0.93%―
Tiaa-cref Funds680,537Institution0.81%―
Bridge Builder Trust576,436Institution0.69%―
Vanguard Scottsdale Funds570,699Institution0.68%―

FAQ

Who Owns PTC Therapeutics (CH:P91)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 87.90% of the company's stock is held by institutional investors, 3.02% is held by insiders, and 9.08% is held by public companies and individual investors.
What percentage of PTC Therapeutics (CH:P91) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 87.90% of PTC Therapeutics (CH:P91) stock is held by institutional investors: 30.34% by mutual funds, 29.06% by ETFs and 28.49% by other institutional investors.
What percentage of PTC Therapeutics (CH:P91) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 9.08% of PTC Therapeutics (CH:P91) stock is held by public companies and individual investors.
Who owns the most shares of PTC Therapeutics (CH:P91)?
BlackRock, Inc. owns the most shares of PTC Therapeutics (CH:P91).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.